Company intelligence / Profile preview

BioSpyder

Carlsbad, California, USA

Ownership: Private
Development stage: Other

Overview

BioSpyder is a privately held biotechnology company founded in 2011, providing molecular biology assay platforms (not therapeutics), notably TempO-Seq and TempO-LINC for gene expression and profiling of mRNA, miRNA, and DNA variants. Their platforms are widely used in research and diagnostics for applications in cancer biology, toxicology, and environmental health. They do not develop therapeutics, so clinical outcome studies are not applicable.

Therapeutic areas: OncologyOther
Modalities: Molecular biology assayGenomic analysisGene expression profiling
Industry: Molecular Diagnostics

Partnerships

BioClavis

Beyond the preview

Go deeper on BioSpyder.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioSpyder.

Explore the full profile